Skip to content
Fencer Intel
high 7.1

CVE-2026-120295 json

Incorrect authorization in the devices page bulk move allows view-role members to move devices into another organization and receive its firmware

published 2d ago modified 14h ago also EUVD-2026-120867 , GHSA-2j7r-q3vm-8j34

Unreviewed: the maintainers' own advisory

Published by the maintainers on their GitHub repository nerves-hub/nerves_hub_web. GitHub has not reviewed it into the GitHub Advisory Database, so the affected packages and versions are the maintainers' word. Read the full advisory on GitHub.

cvss
7.1
version 4.0, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.2%
EPSS 0.2% chance of exploitation in 30 days, percentile 14%
public exploits
0
none known

Summary

Incorrect Authorization vulnerability in the devices page bulk move in nerves-hub nerves_hub_web allows an authenticated user with the manage role in one organization and only the view role in another to move devices into the second organization's product via the "Move device(s) to product" action. The target-product event in NervesHubWeb.Live.Devices.Index looks the product up with NervesHub.Products.get_by_id/2, which checks that the user is a member of the product's organization at any role, and move-devices-product then changes each selected device's organization and product. The device API's move requires manage in the target organization, and an earlier fix added the check on the organization the devices leave but not on the one they enter.

A moved device keeps its key and certificate, joins the target organization's matching deployment groups, and is sent their firmware with a download URL, which the view role cannot otherwise obtain. The user cannot change or control devices that already belong to the other organization.

This issue affects nerves_hub: from 1.0.0 before 2.5.3.

Patch / fix

Is CVE-2026-120295 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

Exploit prediction

0.24% chance of exploitation in the next 30 days, higher than 14% of all scored CVEs (FIRST EPSS, 2026-11-11).

CVSS scores

assigned by version score vector
CNA 4.0 7.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N
CNA 4.0 7.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Affected products

  • nerves-hub nerves_hub_web

Classification

Weakness

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

The maintainers of nerves-hub/nerves_hub_web published their own advisory on GitHub. Reviewed sources take precedence over it.